High-grade serous ovarian carcinoma (HGSOC) accounts for approximately 50% of ovarian cancers and is characterized by TP53 mutations (96%), homologous recombination (HR) DNA repair defects (50%), cyclin E1 (CCNE1) amplification and genomic instability [2]. This evidence concerns the gene CCNE1 and ovarian carcinoma.